Europe's second-largest medical market, almost entirely private-pay and clinic-driven.
The UK legalised medical cannabis in November 2018 and has built Europe's second-largest medical market, almost entirely through private clinics. Regulatory change has been slow but market development rapid, with rising patient numbers, growing domestic cultivation and final-stage manufacturing onshore.
